Table 7

Multivariate analyses of clinical and tumor factors associated with Epcam in 39 HCC patients
Variable P value OR 95%CI
Differentiation (well/moderate/poor) 0.056 5.01 0.96-26.21
TACE Treatment/not 0.025 5.88 1.25-27.80

Zeng et al.

Zeng et al. BMC Cancer 2012 12:584   doi:10.1186/1471-2407-12-584

Open Data